Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

AB Science patents new SCFR inhibitors

Jan. 14, 2015

Argos Therapeutics reports results from phase IIb trial of AGS-004 in HIV-1 infection

Jan. 12, 2015

Merck & Co. reports new HIV integrase inhibitors

Jan. 7, 2015

Janssen and Gilead amend and expand HIV single-tablet regimen development agreements

Dec. 31, 2014

Merck & Co. reports CYP3A4 inhibitors to improve PK of anti-HIV drugs

Dec. 24, 2014

Chimerix and ContraVir establish strategic collaboration for CMX-157

Dec. 23, 2014

Cellectis and bluebird bio report development of HIV treatment

Dec. 19, 2014

ViiV Healthcare applies for Japanese approval of dolutegravir/abacavir/lamivudine

Dec. 16, 2014

Complera combination tablet for HIV-1 launched in Japan

Dec. 15, 2014

FDA gives tentative approval to abacavir/lamivudine pediatric formulations

Dec. 5, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...